OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

OpenAI has reportedly met with officials from the Food and Drug Administration to discuss how AI could speed up drug ...

Industry officials told WSJ the disruptions are leading to longer drug development timelines and increased uncertainty for both companies and investors. One biotech company developing a treatment ...

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug filing.

OpenAI is in talks with the US FDA about using AI, potentially via a project called cderGPT, to assist in drug evaluations, ...